Ashfield U.S., part of UDG Healthcare plc, global commercialization services for the pharmaceutical and healthcare industry, announced the appointment of Amy Van Sant as president of their new Medical Affairs business unit and Lee Ann Chaiken as senior VP of Ashfield s Pharmacovigilance busineOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.